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Potentially malignant oral leukoplakias arise within precancerized epithelial ﬁelds consisting of cytogenetically altered
keratinocytes at various stages of transformation. The evolution of a clone of keratinocytes culminating in a precancerous
phenotype is a function of the number of mutagenic events, rather than the sequential order in which they occur. The altered
molecular conﬁgurations of the transformed precancerous keratinocytes may confer upon them a growth advantage in relation to
theunalteredneighbouringkeratinocytes.Replicativeclonalexpansionofthesekeratinocytesresultsintheprogressivereplacement
of the surrounding normal keratinocytes by the ﬁtter clone or clones of altered cells. The precancerized oral epithelial ﬁeld
may have a clinically normal appearance and microscopically may be normal or may show dysplasia. Oral leukoplakias arising
within a precancerized epithelial ﬁeld in which the keratinocytes show DNA aneuploidy or loss of heterozygosity at certain
speciﬁc chromosomal loci have the potential to progress to carcinoma. The pathogenic mechanisms that drive the carcinomatous
transformation of oral leukoplakias, in which cytogenetic alterations in the keratinocytes cannot be detected, are unknown.
1.Introduction
The genome can sustain a number of alterations to its DNA
without any apparent cellular functional disability, but any
cell that has sustained a critical number of DNA alterations,
such that one or two additional alterations are likely to result
in malignant change, is regarded as being transformed.
I ti se v i d e n tt h a tp o t e n t i a l l ym a l i g n a n to r a ll e u k o -
plakias arise within ﬁelds of precancerization consisting
of cytogenetically altered keratinocytes [1, 2]. A ﬁeld of
precancerization in the oral cavity can be deﬁned as an
area of clinically normal-looking epithelium which is either
microscopically normal or shows dysplasia, but in which
some keratinocytes have undergone cytogenetic alterations
[1–8]. The process of progressive cytogenetic alteration
(transformation) can confer upon the keratinocytes in such
an epithelial ﬁeld a growth advantage in relation to the
normal surrounding keratinocytes [9] so that within an
apparently clinically normal stretch of oral mucosa there can
be a pathobiological continuum from normal epithelium to
precancerized epithelium where carcinoma can arise [7].
2 .A nO ralF iel do fP r ec anc e riz atio n
A ﬁeld of precancerized oral epithelium comprises a large
number of cytogenetically altered keratinocytes at various
stages of transformation. It is not yet clear how many genetic
events are necessary to establish cellular transformation,
and not all the molecular alterations associated with ﬁeld
precancerization of normal-looking oral epithelium have
been characterized [1].
The initial transformational events occur in progenitor
c e l l si nt h eb a s a la n d / o rp a r a b a s a lc e l ll a y e r so ft h eo r a l
epithelium [10, 11]. These progenitor cells give rise to
cells that maintain the integrity of the basal and parabasal
cell layers and to amplifying cells that divide frequently,
producing daughter cells that enter the maturation process,
and gradually progress to the surface of the epithelium [12].
The initial cytogenetic events leading to cell trans-
formation are most probably characterized by molecular
and subsequent functional alterations to genes maintaining
the cell’s genomic stability. Such alterations precipitate
sequential cytogenetic lesions driving the genetic evolution2 International Journal of Dentistry
of the initially transformed progenitor cell towards a cell
with a complete set of genetic alterations of a malignant
phenotype [13–17]. In this regard, the evolution of a
cancerous keratinocyte is the outcome of a suﬃcient number
of accumulated cytogenetic alterations rather than of the
sequential order in which they occur [15, 18–20].
Thecytogeneticalterationsinprecancerouskeratinocytes
reﬂect a noncritical accumulation of molecular events, and
those seen in cancerous keratinocytes are the outcome
of a further critical accumulation of transforming events.
The exact sequence of the cytogenetic molecular events
culminating in carcinogenesis can vary [14, 21].
Most of the cytogenetic and transcriptional alterations
occur early in the continuum from normality, to precancer-
ization, to carcinoma. It is probable that a greater number
of such alterations are required for the transformation of a
normal to a precancerous keratinocyte, than for the trans-
formation of a precancerous keratinocyte to a keratinocyte
expressing a full cancerous phenotype [22].
The number of sequential cytogenetic alterations nec-
essary for a progenitor cell to become a cancer cell is
imponderable, but is estimated to be between 3 and 12.
The exact number of these singular genetic events is a
function of several factors: loss of DNA repair mechanisms,
dysregulation of signal transduction pathways, and blocking
of mechanisms leading to apoptosis [23, 24], which together
will selectively confer an advantage upon the transformed
cellswithregardtocompetitiveﬁtnessandgrowthinrelation
to the surrounding normal cells [9]. This cytogenetic evolu-
tion will promote the clonal expansion of the transformed
cell population and their subsequent clonal divergence to
form either a single precancerized epithelial ﬁeld or multiple
ﬁelds that may be contiguous with or separate from each
other, at the expense of the surrounding normal epithelium
[1].
A ﬁeld of precancerization may comprise a monoclonal
cellpopulationoriginatingfromonetransformedprogenitor
basal cell that underwent clonal expansion, and spread later-
ally. The molecular proﬁle of the transformed keratinocytes
in such a ﬁeld may be identical if they are all part of
a monoclone. On the other hand, the molecular proﬁle
of the transformed keratinocytes may be similar to but
not identical with one another (clonally related) if they
arose from subclones related by descent from the original
monoclone, but each subclone having experienced episodes
of diﬀerent mutations [1, 25–29].
However, a ﬁeld of precancerization may also consist of
a polyclonal cell population, several transformed progenitor
basal cells having undergone independent clonal expansion
with subsequent independent clonal divergence. The molec-
ular proﬁles of the transformed keratinocytes in such a
ﬁeld will be dissimilar, but might share some cytogenetic
alterations, as the polyclonal cells will have been exposed to
identical carcinogens and to the same microenvironment in
the mouth. Thus, the keratinocytes of a unique precancerous
oralleukoplakia or ofa uniqueoralsquamouscellcarcinoma
can show molecular heterogeneity with similar or dissimilar
cytogenetic alterations [1, 25–29].
Theprecancerousﬁeldmaybeclinicallynormal,whether
or not there is epithelial dysplasia. The presence of a ﬁeld
of precancerization may be disclosed by the development
of a leukoplakia or of an erythroplakia, or the appearance
of squamous cell carcinoma will make the nature of the
previously unrecognized ﬁeld of precancerization become all
too apparent [1].
The cytogenetic events culminating in the development
of a ﬁeld of precancerization can be either spontaneous
or microenvironmentally induced, or extraneously imposed,
but it is possible that some ectodermal stem cells destined
to become progenitor cells in the oral epithelium can
actuallyundergogeneticand/orepigeneticalterationsduring
organogenesis, giving rise tocytogeneticallyalteredepithelial
progenitor cells. If during maturation these developmentally
altered keratinocytes are exposed to further transforming
molecularevents,theirclonalexpansioncanculminateinthe
f o r m a t i o no fap r e c a n c e r i z e dﬁ e l d[ 1, 10, 11, 25, 30].
It is possible that dysregulation of gene expression in the
ﬁbroblasts of the lamina propria, with consequent produc-
tion and release of aberrant mediators, may impose upon
the overlying keratinocytes that have already undergone
initial transformation from whatever cause, dysregulatory
inductive signals contributing to the development of the
precancerized ﬁeld [1, 31–33].
3. The Failureof the Studies of
Potentially Malignant Lesions to Contribute
to Knowledge of PotentiallyMalignant
Lesions of the Mouth
There are a number of potentially malignant lesions of
the upper aerodigestive tract in which the oral cavity,
nasopharynx, oropharynx, hypopharynx, and the larynx,
are grouped together as if premalignancies of these sites
constitute a homogeneous group. Potentially malignant
lesions from these various sites are, however, site speciﬁc, so
such studies are of limited value in isolating molecular and
cytogeneticmarkersofcarcinomatoustransformationoforal
leukoplakia [1].
Furthermore, although the potentially malignant lesions
of the upper aerodigestive tract have common histological
features of epithelial dysplasia or hyperplasia, they certainly
do not have similar clinical features or natural courses. In
addition, in several studies, oral epithelial dysplasia and
hyperplasia have been chosen as the inclusion criteria for
categorising oral lesions as being potentially malignant,
withoutdiﬀerentiatingtheclinicalentities.Moreover,certain
reactiveandinﬂammatorylesionsoftheoralmucosaexhibit-
ing epithelial hyperplasia or low-grade dysplasia have been
erroneously included in some of the studies although these
lesions will never undergo carcinomatous transformation
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4.Molecular Markers of Oral Leukoplakia and
Its ProgressiontoSquamousCell Carcinoma
The development of precancerous oral leukoplakia and its
carcinomatous transformation can be brought about by dys-
regulation of the mechanisms controlling the cell cycle, DNA
repair, and apoptosis, by activation of proto-oncogenes, by
loss of chromosomal regions containing candidate tumour-
suppressor genes as a result of loss of heterozygosity (LoH),
and by alterations to genomic DNA and to mitochondrial
DNA [23–25, 34, 35]. While these molecular and cytogenetic
markers may not be reliable predictors of carcinomatous
transformation [1, 34, 36–38], there is a good deal of
evidence that LoH at speciﬁc chromosomal arms, and
aneuploidy, are indeed associated with increased frequency
ofcarcinomatoustransformationoforalleukoplakia[35,39–
43]. However, irrespective of one or more cytogenetic or
molecular changes to the keratinocytes of oral leukoplakia,
progression to carcinoma may never occur [1].
LoHatthechromosomearms3pand9poccurfrequently
in keratinocytes of precancerous epithelial lesions of the
upper aerodigestive tract. This pattern of LoH can be associ-
ated with carcinomatous transformation of these lesions [18,
35, 40, 44, 45]. In one study, precancerous epithelial lesions
with keratinocytes having LoH limited to 3p and/or 9p
had a 3.8-fold higher risk of carcinomatous transformation
compared to precancerous lesions without LoH either at
3p or at 9p, while those lesions with keratinocytes carrying
LoH at 3p and/or 9p, together with additional losses at any
of the chromosomes 4q, 8p, 11q, and 17p had a 33-fold
increased risk of carcinomatous transformation, compared
to precancerous lesions with keratinocytes retaining these
chromosomal arms, and also progressed to carcinoma more
rapidly, although unpredictably [35, 41].
For unknown reasons, keratinocytes of dysplastic oral
leukoplakias on the ﬂoor of the mouth, on the ventrolateral
surface of the tongue, and at the maxillary retromolar/soft
palate region have LoH more frequently than do the ker-
atinocytes of dysplastic leukoplakias aﬀecting other regions
of the oral mucosa. This may be one of the factors
putting leukoplakias at the three sites of the oral mucosa
mentioned, at higher risk of carcinomatous transformation
than leukoplakias at other lower-risk sites [41].
Notwithstanding, the increased risk of carcinomatous
transformation associated with LoH in precancerous epithe-
lial lesions, not all oral leukoplakias with keratinocytic
LoH, will progress to carcinoma, and as some oral leuko-
plakias without keratinocytic LoH will indeed progress to
carcinoma, LoH is certainly not an infallible predictor of
carcinomatous transformation [1].
It seems that the presence of DNA aneuploidy in
keratinocytesoforalleukoplakiamaybeavaluablemolecular
marker of carcinomatous transformation of oral leukoplakia
and an indicator of poor prognosis. The frequency of
carcinomatous transformation of dysplastic oral leukoplakia
is much greater for those leukoplakias with keratinocytes
showing DNA aneuploidy than for those with keratinocytes
with normal (diploid) DNA content, and subjects with
oral carcinoma developing from dysplastic leukoplakia with
keratinocytes manifesting aneuploidy have a lower rate of
survival compared to subjects with oral squamous cell
carcinoma evolving from dysplastic leukoplakia with ker-
atinocytes with diploid DNA content [43, 46].
5. FieldPrecancerizationandOral Leukoplakia
The existence of a ﬁeld or ﬁelds of precancerization can
explain why oral leukoplakia may manifest at single or at
multiple sites, synchronously and/or metachronously and
may recur at the same site from which it was previously
apparently successfully excised [1]
Additional cytogenetic alterations superimposed upon
transformed precancerous keratinocytes either within a
leukoplakia or within a clinically normal-looking zone of
an epithelial ﬁeld of precancerization may drive the process
of cancerization. This explains why sometimes an oral
leukoplakia on microscopical examination is found to have
already become squamous cell carcinoma, and sometimes
squamous cell carcinoma arises apparently de novo either
contiguous to or separated from existing leukoplakia. If a
substantial portion of a ﬁeld of precancerization arises from
a monoclone of cytogenetically transformed keratinocytes,
then any leukoplakias, or subsequently developing carcino-
masarisingwithinthatﬁeldeithercontiguouslyorseparately
from each other, will be cytogenetically very similar or
identical. On the other hand, if a ﬁeld of precancerization
comprises a number of clones of cytogenetically dissimilarly
transformed keratinocytes, then leukoplakias or carcinomas
arisingwithinthisﬁeld(ifmultiplelesionsshouldoccur)will
be cytogenetically dissimilar [1, 30].
The transformed keratinocytes in the precancerized ﬁeld
from which a leukoplakia had apparently been completely
excised may give rise to “recurrence” of another leukoplakia
from cytogenetically related subclones of transformed ker-
atinocytes adjacent to the surgical excision or from adjacent
cytogenetically unrelated clones [45].
The time of progression of oral leukoplakias with
keratinocytes with molecular proﬁles associated with car-
cinomatous transformation, to squamous cell carcinoma if
it occurs, unpredictably and inexplicably varies from six
months to eight years [35, 41]. However, it may sometimes
take more than 30 years for oral leukoplakia to progress
to squamous cell carcinoma [47], and the average period
for carcinomatous transformation ranges from 5 to 8 years
[47, 48]. Neither the rate of progression of oral leukoplakia
to carcinoma nor the mechanisms bringing about the
regression of oral leukoplakia, can be explained in terms of
the cytogenetic characteristics of the precancerous ﬁeld.
The mechanisms that bring about regression of oral
leukoplakia in which the keratinocytes harbour cytogenetic
changes associated with early transformational events are
obscure. However, it is possible that a continuous accumula-
tionofcytogeneticalterationsmaygiverisetoaprecancerous
clone of cells that is inferior rather than superior in its
competitive growth and ﬁtness resulting in its replacement
by, rather than in its replacing, the normal neighbouring4 International Journal of Dentistry
keratinocytes [1]. Alternatively, or additionally, the accumu-
lated cytogenetic alterations may result in failure of DNA
replication and cell viability leading to the extinction of the
precancerous clone [14].
6. Summary
Despite advances in molecular genetic studies, there are no
molecular markers that are reliable predictors of progression
of oral leukoplakia to carcinoma. Although some oral
leukoplakias arise within ﬁelds of precancerized epithelium
where initial cytogenetic alterations have already occurred,
their transformed keratinocytes may or may not acquire
complete malignant phenotypes.
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